Opens in a new tab

Breaking news

Alpha Bank Reports Strong Underlying Q1 Performance Despite Capital Pressure

Robust Operational Performance

Alpha Bank’s first quarter 2026 report demonstrates a solid operational foundation, as confirmed by analyses from leading institutions such as Citi, JPMorgan, Jefferies, and Deutsche Bank. Despite an accounting impact from extraordinary one-off costs, the bank’s commercial momentum remains unmistakable, driven notably by fee income and resilient net interest margins.

Capital Position And Extraordinary Items

Quarterly results were weighed down by a lower-than-expected capital ratio and a €47 million expense linked to a voluntary exit program affecting around 350 employees. As a result, net profit totaled €182 million, falling 9% below market consensus. At the same time, the restructuring initiative is expected to generate annual savings of approximately €15 million.

Operating Metrics And Investor Insights

Analysts highlighted the strength of Alpha Bank’s underlying operations after adjusting for extraordinary items. Adjusted net profit reached €221 million, exceeding market expectations by 2%. Fee income increased 29% year-on-year to €140 million, supported by higher revenue from business lending fees, insurance services, investment banking and wealth management activities. Performing exposures and assets under management also reached record levels during the quarter, reinforcing the bank’s efforts to diversify revenue streams beyond interest income.

Market Valuation And Sector Commentary

Market commentary following the results remained broadly positive despite pressure on some balance-sheet metrics. JPMorgan described the quarter as showing underlying strength, while Deutsche Bank and Jefferies maintained buy recommendations with target prices reaching €4.85. At the same time, analysts continued to monitor pressure on net interest margins and dilution in common equity tier 1 ratios as banks adapt to changing market conditions.

Strategic Outlook

Alpha Bank is expected to provide additional details on its medium-term strategy during its investor day scheduled for the second half of 2026. Key areas of focus are expected to include the sustainability of fee income growth, capital trajectory management and shareholder returns. The bank has also maintained its earnings per share target of €0.40 for 2026, representing projected year-on-year growth of 11%.

First-quarter results highlighted Alpha Bank’s ability to maintain operational momentum despite pressure from one-off costs and capital-related challenges. Growth in fee-based activities and continued expansion in assets under management also reflected the bank’s broader effort to strengthen revenue diversification across its business segments.

Oura To Acquire Counsel Health For $625 Million As It Expands Into Medical Care

Smart-ring maker Oura is expanding beyond health tracking into medical services through a $625 million acquisition of AI-powered primary care company Counsel Health. Announced on Tuesday, the deal builds on an existing partnership that has brought virtual medical support directly into the Oura app.

The acquisition comes weeks after Oura indefinitely postponed plans for an initial public offering that could have raised up to $2.2 billion, citing uncertainty in the IPO market. Instead, the company is pursuing growth by broadening its healthcare offering and giving its biometric data a more direct role in medical care.

From Health Tracking To Medical Services

Counsel combines an AI-powered, chat-based medical service with access to licensed physicians. Its platform was integrated into the Oura app in June, allowing members to receive personalised guidance through medical AI and consult a doctor when necessary.

The companies plan to expand the integration across preventive, acute, specialist and chronic care. Members can already use the service for a range of needs, including medical questions, prescriptions, laboratory results, ongoing treatment and referrals.

“Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs,” Oura CEO Tom Hale said in the announcement.

The strategy connects continuous biometric monitoring with clinical services. Data collected by wearable devices can give doctors additional insight into changes in a patient’s health over time, while access to medical professionals can help users translate those observations into practical decisions. For Oura, the move also creates an opportunity to expand beyond hardware and subscriptions into a more comprehensive healthcare service.

Competition In The Smart-Ring Market

Oura has established itself as a leading player in the smart-ring category, but competitors such as RingConn and Ultrahuman are challenging its position. Adding medical services could help the company differentiate its platform as competition for consumers’ attention and spending intensifies.

Counsel will also continue serving existing and new enterprise partners after the acquisition closes. This gives Oura an opportunity to extend the company’s AI-enabled care model beyond its own membership base.

Counsel Team To Join Oura

Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, alongside the company’s approximately 70 employees, Bloomberg reported.

Counsel raised a $25 million Series A round a year ago, led by Andreessen Horowitz and GV. According to PitchBook, the company has raised $36 million in total.

Alagappan said Counsel developed its medical AI around trust, safety and physician involvement in clinical decisions. He also highlighted the potential of Oura’s data to provide clinicians with objective health context, biometric trends and information about how members engage with their care.

The acquisition is expected to close before the end of 2027.

Strong Revenue Growth Despite IPO Delay

The deal comes as Oura reports significant revenue growth. Revenue increased 153% year over year to $533 million in the quarter ended September 30. For fiscal 2026, the company generated approximately $1.75 billion, up 92% from the previous year.

Oura reached an $11 billion valuation after raising $900 million in a late-stage funding round in October 2025. With its IPO plans on hold, the Counsel acquisition represents a major investment in a new growth direction: combining consumer health data with personalised medical care.

Aretilaw firm
eCredo
Uol
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter